Nalmefene for reducing alcohol consumption in people with alcohol dependence: evaluation report

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the technology manufacturer – Lundbeck UK

03 - NICE request to the manufacturer for clarification on their submission

04 - Manufacturer clarification response

05 – Additional manufacturer clarification response

06 - Consultee submission – ADFAM

07 - Consultee submission – Alcohol Concern

08 - Consultee submission – Royal College of Nursing

09 – Clinical expert personal perspective – Daly

10 – Clinical expert personal perspective – Greasley

11 – Patient expert personal perspective – Langford

12 – Patient expert personal perspective – Standing

13 - Evidence Review Group report prepared by the School of Health and Related Research (ScHARR)

14 - Manufacturer factual accuracy check of Evidence Review Group report


Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.



This page was last updated: 13 March 2015